| Date Filed | Type | Description |
| 10/04/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 15,873 shares
@ $0 |
|
| 07/06/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 6,079 shares
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 25,510 shares
@ $0
Granted 49,237 options to buy
@ $3.92, valued at
$193k
|
|
| 06/12/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 04/05/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 4,866 shares
@ $0 |
|
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,000,439 options to buy
@ $0 |
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.|
Txns:
| Granted 8,500 options to buy
@ $1.07, valued at
$9.1k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 20,653 shares
@ $1.15, valued at
$23.8k
|
|
| 02/23/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.|
Txns:
| Bought 50,398 shares
@ $1.3, valued at
$65.5k
Bought 65,817 shares
@ $1.56, valued at
$102.7k
Bought 35,257 shares
@ $1.46, valued at
$51.5k
|
|
| 02/17/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.|
Txns:
| Bought 19,552 shares
@ $1.2, valued at
$23.5k
Bought 11,779 shares
@ $1.2, valued at
$14.1k
Bought 14,595 shares
@ $1.17, valued at
$17.1k
|
|
| 02/14/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.|
Txns:
| Bought 8,753 shares
@ $1.29, valued at
$11.3k
Bought 14,573 shares
@ $1.23, valued at
$17.9k
Bought 8,500 shares
@ $1.18, valued at
$10k
|
|
| 01/05/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 18,518 options to buy
@ $6.44, valued at
$119.3k
|
|
| 01/04/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 9,500 shares
@ $2.5, valued at
$23.8k
|
|
| 10/01/2021 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 4,640 shares
@ $5.12, valued at
$23.8k
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 579,494 options to buy
@ $0 |
|
| 07/01/2021 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 2,858 shares
@ $8.31, valued at
$23.7k
|
|
| 06/30/2021 |
4
| MOTT DAVID M (Director) has filed a Form 4 on IMARA Inc.|
Txns:
| Granted 7,728 options to buy
@ $8.12, valued at
$62.8k
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,060 shares
@ $0
Granted 40,559 options to buy
@ $8.53, valued at
$346k
|
|
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 4,528 options to buy
@ $21.09, valued at
$95.5k
|
|
|